InvestorsHub Logo
Followers 1
Posts 29
Boards Moderated 0
Alias Born 08/23/2016

Re: None

Monday, 10/17/2016 2:30:58 PM

Monday, October 17, 2016 2:30:58 PM

Post# of 40993
NASS Program

There are some very interesting references to Amedica in the NASS conference program:

https://www.spine.org/Portals/0/Documents/Education/AM16FinalProgram.pdf

Marketing on the new pedicle screw system:



AMDA not only got a booth, but they got a private suite. Suite-based conference marketing is meant for personal, small-group marketing of products and ideas not meant for the general conference floor. Suite-based marketing at conferences can also require registration with the company and/or an NDA to attend. Draw your own conclusions on this.



AMDA is listed under the category of "bone substitute material" company, one of the first public references to CsC that I have seen:



AMDA is also listed under the category of "synthetic bone graft substitute" companies, an even more direct reference to CsC:



Also of note, you can do a text search of the program PDF listed above for "Amedica" and see the list of disclosures as to which doctors own stock, provide consulting, and receive royalties with Amedica.

Based on this, I believe it is logical to expect some sort of PR from the company to land Monday or Tuesday next week before the conference starts on Wednesday. They are investing heavily making a splash at this conference.


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SINT News